Literature DB >> 19255442

LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation.

Natalya V Belkina1, Yin Liu, Jian-Jiang Hao, Hajime Karasuyama, Stephen Shaw.   

Abstract

ERM (ezrin-radixin-moesin) proteins mediate linkage of actin cytoskeleton to plasma membrane in many cells. ERM activity is regulated in part by phosphorylation at a C-terminal threonine, but the identity of ERM kinases is unknown in lymphocytes and incompletely defined in other mammalian cells. Our studies show that lymphocyte-oriented kinase (LOK) is an ERM kinase in vitro and in vivo. Mass spectrometric analysis indicates LOK is abundant at the lymphocyte plasma membrane and immunofluorescence studies show LOK enrichment at the plasma membrane near ERM. In vitro peptide specificity analyses characterize LOK as a basophilic kinase whose optimal substrate sequence resembles the ERM site, including unusual preference for tyrosine at P-2. LOK's activity on moesin peptide and protein was comparable to reported ERM kinases ROCK and PKC but unlike them LOK displayed preferential specificity for moesin compared to traditional basophilic kinase substrates. Two genetic approaches demonstrate a role for LOK in ERM phosphorylation: cell transfection with LOK kinase domain augments ERM phosphorylation and lymphocytes from LOK knockout mice have >50% reduction in ERM phosphorylation. The findings on localization and specificity argue that LOK is a direct ERM kinase. The knockout mice have normal hematopoietic cell development but notably lymphocyte migration and polarization in response to chemokine are enhanced. These functional alterations fit the current understanding of the role of ERM phosphorylation in regulating cortical reorganization. Thus, these studies identify a new ERM kinase of importance in lymphocytes and confirm the role of ERM phosphorylation in regulating cell shape and motility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255442      PMCID: PMC2660762          DOI: 10.1073/pnas.0805963106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Rigidity of circulating lymphocytes is primarily conferred by vimentin intermediate filaments.

Authors:  M J Brown; J A Hallam; E Colucci-Guyon; S Shaw
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation.

Authors:  Sophie Faure; Laura Inés Salazar-Fontana; Monique Semichon; Victor L J Tybulewicz; Georges Bismuth; Alain Trautmann; Ronald N Germain; Jérôme Delon
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

Review 3.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

4.  Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes.

Authors:  Ruchika Nijhara; Paula B van Hennik; Michelle L Gignac; Michael J Kruhlak; Peter L Hordijk; Jerome Delon; Stephen Shaw
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

5.  Enrichment of distinct microfilament-associated and GTP-binding-proteins in membrane/microvilli fractions from lymphoid cells.

Authors:  Jian-Jiang Hao; Guanghui Wang; Trairak Pisitkun; Genaro Patino-Lopez; Kunio Nagashima; Mark A Knepper; Rong-Fong Shen; Stephen Shaw
Journal:  J Proteome Res       Date:  2008-05-28       Impact factor: 4.466

6.  Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases.

Authors:  T Matsui; S Yonemura; S Tsukita; S Tsukita
Journal:  Curr Biol       Date:  1999-11-04       Impact factor: 10.834

7.  Deficiency of a STE20/PAK family kinase LOK leads to the acceleration of LFA-1 clustering and cell adhesion of activated lymphocytes.

Authors:  J Endo; N Toyama-Sorimachi; C Taya; S Kuramochi-Miyagawa; K Nagata; K Kuida; T Takashi; H Yonekawa; Y Yoshizawa; N Miyasaka; H Karasuyama
Journal:  FEBS Lett       Date:  2000-02-25       Impact factor: 4.124

8.  Kinase peptide specificity: improved determination and relevance to protein phosphorylation.

Authors:  Koichi Fujii; Guozhi Zhu; Yin Liu; John Hallam; Lin Chen; Juan Herrero; Stephen Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-08       Impact factor: 11.205

9.  Slik Sterile-20 kinase regulates Moesin activity to promote epithelial integrity during tissue growth.

Authors:  David R Hipfner; Nadine Keller; Stephen M Cohen
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

10.  Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.

Authors:  Jong-Hwan Lee; Tomoya Katakai; Takahiro Hara; Hiroyuki Gonda; Manabu Sugai; Akira Shimizu
Journal:  J Cell Biol       Date:  2004-10-25       Impact factor: 10.539

View more
  67 in total

1.  Comprehensive characterization of the Published Kinase Inhibitor Set.

Authors:  Jonathan M Elkins; Vita Fedele; Marta Szklarz; Kamal R Abdul Azeez; Eidarus Salah; Jowita Mikolajczyk; Sergei Romanov; Nikolai Sepetov; Xi-Ping Huang; Bryan L Roth; Ayman Al Haj Zen; Denis Fourches; Eugene Muratov; Alex Tropsha; Joel Morris; Beverly A Teicher; Mark Kunkel; Eric Polley; Karen E Lackey; Francis L Atkinson; John P Overington; Paul Bamborough; Susanne Müller; Daniel J Price; Timothy M Willson; David H Drewry; Stefan Knapp; William J Zuercher
Journal:  Nat Biotechnol       Date:  2015-10-26       Impact factor: 54.908

Review 2.  Emerging role for ERM proteins in cell adhesion and migration.

Authors:  Monique Arpin; Dafne Chirivino; Alexandra Naba; Ingrid Zwaenepoel
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

Review 3.  RHO GTPases: from new partners to complex immune syndromes.

Authors:  Rana El Masri; Jérôme Delon
Journal:  Nat Rev Immunol       Date:  2021-02-05       Impact factor: 53.106

4.  Merlin/ERM proteins establish cortical asymmetry and centrosome position.

Authors:  Alan M Hebert; Brian DuBoff; Jessica B Casaletto; Andrew B Gladden; Andrea I McClatchey
Journal:  Genes Dev       Date:  2012-12-15       Impact factor: 11.361

5.  Dynamics of ezrin and EBP50 in regulating microvilli on the apical aspect of epithelial cells.

Authors:  Raghuvir Viswanatha; Anthony Bretscher; Damien Garbett
Journal:  Biochem Soc Trans       Date:  2014-02       Impact factor: 5.407

Review 6.  The ezrin-radixin-moesin family of proteins in the regulation of B-cell immune response.

Authors:  Debasis Pore; Neetu Gupta
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

7.  Sip1, the Drosophila orthologue of EBP50/NHERF1, functions with the sterile 20 family kinase Slik to regulate Moesin activity.

Authors:  Sarah C Hughes; Etienne Formstecher; Richard G Fehon
Journal:  J Cell Sci       Date:  2010-03-09       Impact factor: 5.285

8.  Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.

Authors:  Djanybek M Adyshev; Nurgul K Moldobaeva; Venkateswaran R Elangovan; Joe G N Garcia; Steven M Dudek
Journal:  Cell Signal       Date:  2011-08-12       Impact factor: 4.315

9.  Immunohistochemical examination for the distribution of podoplanin-expressing cells in developing mouse molar tooth germs.

Authors:  Yuri Imaizumi; Ikuko Amano; Eichi Tsuruga; Hiroshi Kojima; Yoshihiko Sawa
Journal:  Acta Histochem Cytochem       Date:  2010-10-15       Impact factor: 1.938

10.  Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1.

Authors:  Amanda Hurley; Mindy Smith; Tatiana Karpova; Rebecca B Hasley; Natalya Belkina; Stephen Shaw; Nariman Balenga; Kirk M Druey; Erin Nickel; Beverly Packard; Hiromi Imamichi; Zonghui Hu; Dean Follmann; James McNally; Jeanette Higgins; Michael Sneller; H Clifford Lane; Marta Catalfamo
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.